Deprescribing Super Special Part II: Podcast with Elizabeth Bayliss, Ariel Green, and Kevin McConeghy
GeriPal
AUGUST 4, 2022
My take home from this is that while the most preferred explanation for deprescribing statins and sedative-hypnotics is one focused on the risk of side effects, we also need to individualize it to the patient and the medication that they are taking. Alex: No, I think we did one other super special. Alex: So this is Super special 2.
Let's personalize your content